Venous thromboembolism (VTE) prevention with semuloparin in cancer patients initiating chemotherapy: benefit-risk assessment by VTE risk in SAVE-ONCO

Pas encore traduit Pas encore traduit
Catégorie Primary study
Conférence53rd Annual Meeting of the American Society of Hematology (Published in: Blood 2011;118(21):96)
Year 2011

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
This article is part of the following matrixes of evidence:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: 156109c949f9848301fcee1774ff5be8563a370e
First added on: Mar 14, 2016